Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
6.86
-0.04 (-0.58%)
Jul 7, 2025, 2:45 PM CST
SHE:002082 Revenue
Wanbangde Pharmaceutical Holding Group had revenue of 315.11M CNY in the quarter ending March 31, 2025, a decrease of -26.58%. This brings the company's revenue in the last twelve months to 1.33B, down -16.18% year-over-year. In the year 2024, Wanbangde Pharmaceutical Holding Group had annual revenue of 1.44B, down -6.39%.
Revenue (ttm)
1.33B
Revenue Growth
-16.18%
P/S Ratio
3.18
Revenue / Employee
886.79K
Employees
1,499
Market Cap
4.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.44B | -98.57M | -6.39% |
Dec 31, 2023 | 1.54B | -244.49M | -13.69% |
Jan 1, 2023 | 1.79B | -144.17M | -7.47% |
Jan 1, 2022 | 1.93B | -11.77B | -85.91% |
Dec 31, 2020 | 13.70B | -2.99B | -17.91% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |